Home / Letter From The Editor / Nov. 28, 2017

Nov. 28, 2017

Nov 28, 2017

Dr Aaron Vinik has worked with us for many years and I am continually fascinated by his forward thinking and the respect he garners from the top opinion leaders in diabetes.

Over the past 10 years, there have been researchers who seem to have a left-field idea that may just work, but they are often in the spotlight for a short time and then they and their ideas are forgotten. Dr. Vinik is not one of those.

His early research in the use of the INGAP protein started a thought process in diabetes that is still evolving. He was one of the early adapters of medications that improve cardiovascular health in diabetes patients. Steve caught up with him at the recent AACE convention in Austin, where he shared what he is doing to improve cardiovascular outcomes. Last week, he got started talking about diabetes drugs that improve cardiovascular outcomes and this week he spends some extra time on his favorite drug for those patients.

Dave Joffe